Form 4: Palantir Director Sells Shares Under 10b5-1 Plan

Palantir Technologies Inc. Director Lauren Elaina Friedman sold 800 shares of Class A Common Stock for $186.39 per share pursuant to a pre-arranged Rule 10b5-1 trading plan.

Summary

• Lauren Elaina Friedman, a Director of Palantir Technologies Inc. (PLTR), sold 800 shares of Class A Common Stock.
• The transaction occurred on October 3, 2025, at a price of $186.39 per share.
• The sale was executed under a Rule 10b5-1 trading plan, which was established on September 12, 2024.
• Following this transaction, Ms. Friedman directly beneficially owns 62,087 shares of Class A Common Stock.
• Additionally, Ms. Friedman indirectly beneficially owns 50,794 shares through her spouse and 7,335 shares through her child's 2025 gift trust, for which she serves as trustee.

Sentiment

Score: 6

Explanation: The sale of shares by a director is generally a neutral to slightly negative signal. However, the execution under a Rule 10b5-1 plan mitigates any strong negative interpretation, as it indicates a pre-scheduled transaction rather than a reaction to new information. The relatively small number of shares sold also limits its impact.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on new, non-public information.

Negatives

• A director selling shares, even under a pre-arranged plan, reduces insider ownership and can be perceived as a slight negative signal by some investors.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• This Form 4 has been compiled based on applicable requirements to reflect the specific transactions described herein and is not intended to disclose or describe all shares and/or other equity securities owned or beneficially held by the Reporting Person.

Industry Context

Insider transactions, particularly sales, are common across all industries. Sales executed under Rule 10b5-1 plans are generally viewed as routine personal financial management rather than a signal about the company's immediate prospects, distinguishing them from opportunistic sales.

Stakeholder Impact

• Minor impact on shareholders due to a reduction in direct insider ownership, though mitigated by the pre-arranged nature of the sale.

Next Steps

• The filing refers to the Issuer's Proxy Statement filed on April 25, 2025, for additional details regarding the Reporting Person's overall stock and equity holdings.

Key Dates

Keywords

Palantir Technologies, PLTR, Insider Trading, Form 4, Stock Sale, Director, Lauren Elaina Friedman, 10b5-1 Plan, Equity Transaction